Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial. - Gladwin MT; Gordeuk VR; Desai PC; Minniti C; Novelli EM; Morris CR; Ataga KI; De Castro L; Curtis SA; El Rassi F; Ford HJ; Harrington T; et al. (The Lancet. Haematology, 2024)